Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Sarepta Therapeutics provided $15m in a series A round for the company, which is advancing University of Florida research.

Incubated by Vision Institute, the retinal disease gene therapy developer has secured $52.8m in a round co-led by UPMC Enterprises.

QUB spinout ProAxsis has been fully acquired by NetScientific, which previously backed the company’s sole funding round in 2014.

Sarepta Therapeutics provided $15m in a series A round for the startup, which is working on genetic medicines for rare diseases.

The retinal disease gene therapy developer has secured $52.8m in a round co-led by UPMC Enterprises that will go toward further developing its drug pipeline.

Nine companies will participate in the internet company’s three-month accelerator programme, which is set to launch next month.

The UC Berkeley spinout has been snapped up by Astellas, two years after the latter took part in its series A round.

Insurer MACSF has taken part in round for patient data tool provider Savana, which will use the cash to expand to the US market.

Providence Health and Services has exited the healthcare satisfaction analyser in a purchase of undisclosed size by Press Ganey.